Clinical trial
Immunoadsorption of LPS, C5a and IL-6 in Severe Sepsis and Septic Shock…
NCT00146432 · Charite University, Berlin, Germany, Other · Completed
Key facts
| NCT number | NCT00146432 |
|---|---|
| Title | Immunoadsorption of LPS, C5a and IL-6 in Severe Sepsis and Septic Shock (ISASS-1) |
| Official title | Prospective, Controlled Pilot Trial: Treatment of Patients in Severe Sepsis and Septic Shock With Immunoadsorption of LPS, IL-6, C5a |
| Lead sponsor | Charite University, Berlin, Germany, Other |
| Collaborators | German Research Foundation adexter GmbH Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Septicemia |
| Intervention type | Procedure |
| Interventions | Immunoadsorption of LPS, IL-6 and C5a |
| First posted | Sep 7, 2005 |
| Last update posted | Aug 25, 2009 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: